0.00
—
Close of 30 Oct 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Medivolve
Its shares trade under the ticker MEDVF. It has been listed since 16 November 2009. In the fiscal year to 31 December 2023, it reported revenue of C$686,500 and a net loss of C$16.7m. At that date it held total assets of C$2.4m and shareholders' equity of −C$15.8m.
Medivolve, Inc. engages in seeking technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate risk-adjusted returns for investors. The company is headquartered in Toronto, Ontario. The company went IPO on 2009-11-16. The firm has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The firm has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 16 Nov 2009
- Website
- medevolve.com ↗
Leadership
Pay as last reported
- Mr. Indivar PathakChief Operating Officer, Collection SitesC$834,480
- Mr. Neil SaidGeneral CounselC$1.0m
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Medivolve Pharmacy Division serves Southern California with specialized pharmacy services.
- Collection Sites Diagnostics offers EHR software for clinical staff and lab solutions.
- The company has operated two retail locations in California for patient care.
Weaknesses
- Medivolve Pharmacy Division focuses on Southern California limiting broader market reach.
- CSD's EHR app is limited to clinical staff without broader healthcare integration.
- The firm has only two retail locations in California for patient care.
Opportunities
- Expanding MPD services to other U.S. regions could increase patient base.
- Growing demand for telehealth services presents new market opportunities.
- CSD's EHR platform can be integrated with more healthcare providers.
Threats
- Competition from established pharmacy chains in Southern California.
- Regulatory changes in the U.S. healthcare sector could impact operations.
- Economic downturns may reduce patient visits to retail locations.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.